173 results
8-K
EX-99.2
MDVLQ
MedAvail Holdings Inc
30 Mar 21
MedAvail Reports Fourth Quarter and Full Year 2020 Financial Results
5:30pm
Medication Adherence and Satisfaction LOCALIZED FULFILLMENT MedicationsLive A/V connection to pharmacist Pharmacy technicians Pharmacist consultation … / Payor SATISFACTION Patients Net Promoter Score (NPS) ~90 * CMS Star Rating Bands 2020, SpotRx measure over 12 month period from January 2020
8-K
EX-99.1
MDVLQ
MedAvail Holdings Inc
19 May 21
Results of Operations and Financial Condition
5:00pm
Scale Through Technology and Centralized Hubs Unique Pharmacy Model Results in Superior Medication Adherence and Satisfaction 1 Open CENTRALIZED … Opportunities to drive adherence and satisfaction among clinic patients
9 SpotRx Pharmacy Model Provides Differentiated Value Proposition On-site
8-K
EX-99.2
MDVLQ
MedAvail Holdings Inc
8 Nov 21
MedAvail Reports Third Quarter 2021 Financial Results
4:08pm
and spoke model Unique Pharmacy Model Results in Superior Medication Adherence and Satisfaction 1 Open CENTRALIZED PHARMACY HUB in Each SpotRx Service … staff Opportunities to drive adherence and satisfaction among clinic patients
8 SpotRx Pharmacy Model Provides Differentiated Value Proposition
8-K
EX-99.1
MDVLQ
MedAvail Holdings Inc
10 Sep 21
Regulation FD Disclosure
8:29pm
Achieves Scale Through Technology and Centralized Hubs Unique Pharmacy Model Results in Superior Medication Adherence and Satisfaction 1 Open CENTRALIZED … staff ✓ Opportunities to drive adherence and satisfaction among clinic patients
9 SpotRx Pharmacy Model Provides Differentiated Value Proposition
425
EX-99.1
MDVLQ
MedAvail Holdings Inc
3 Nov 20
Business combination disclosure
5:15pm
, and Matrix Merger Sub, Inc., a newly-created wholly-owned subsidiary of MYOS (“Merger Sub”), pursuant to which, subject to the satisfaction or waiver … to the satisfaction or waiver of the conditions set forth in the Merger Agreement, with the first $1.0 million being paid upon the closing
8-K
EX-99.1
ayx 7gtp98nn3dwt4s
4 Apr 22
Entry into a Material Definitive Agreement
5:16pm
8-K
EX-99.1
k7yb 0j42kw
3 Nov 20
Other Events
5:17pm
8-K
EX-99.2
88ge8lj
10 Nov 22
MedAvail Reports Third Quarter 2022 Financial Results
4:06pm
8-K
EX-99.3
yewihy56xak6o3r
14 Aug 23
MedAvail Reports Second Quarter 2023 Financial Results
4:53pm
8-K
EX-99.2
xa6ytiru
4 Apr 22
Entry into a Material Definitive Agreement
5:16pm
8-K
EX-99.2
i538uzzmie9xd4 3wo
11 Aug 22
MedAvail Reports Second Quarter 2022 Financial Results
4:06pm
8-K
EX-99.2
2zi26le554y7m 1uue8y
12 May 22
MedAvail Reports First Quarter 2022 Financial Results
4:12pm
8-K
EX-4.1
5hram2zr5ttlkatzcwzz
18 Nov 20
Report of Independent Auditors
8:00am
425
bvg7k795q0a49pp2
30 Jun 20
Business combination disclosure
4:45pm
8-K
zqwkjz
1 Jul 22
Unregistered Sales of Equity Securities
4:56pm
8-K
ovmio0
4 Apr 22
Entry into a Material Definitive Agreement
5:16pm
8-K
dp3i emmy
17 Nov 20
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding
8:02am
8-K
EX-99.1
dgu3zw5c825c
17 Nov 20
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding
8:02am
425
EX-99.1
vcwcl1394bxc52j7
12 Nov 20
Business combination disclosure
4:30pm
8-K
EX-99.1
ua50o
12 Nov 20
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger
4:32pm